Anti-IGFBP6 antibody

Cat.#: 141424

Size:

Special Price 193.4 USD

Availability:
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-IGFBP6 antibody
  • Documents
  • Description
    Rabbit Monoclonal to Mouse IGFBP6
  • Tested applications
    ELISA, IHC-P
  • Species reactivity
    Mouse IGFBP6 / IBP6
  • Alternative names
    IBP-6 antibody; IBP-6 antibody; IBP6 antibody; Igfbp6 antibody; IGFBP6 antibody; IGFBP-6 antibody; IGFBP-6 antibody; IBP6 antibody; IGFBP-6 antibody
  • Immunogen
  • Isotype
    Rabbit IgG
  • Preparation
    This antibody was obtained from a rabbit immunized with purified, recombinant Mouse IGFBP6 / IBP6 .
  • Clonality
    Monoclonal
  • Formulation
    0.2 μm filtered solution in PBS
  • Storage instructions
    This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
    Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
  • Applications

    ELISA: 0.1-0.2 μg/mL

    This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Mouse IGFBP6 / IBP6.

    IHC-P: 1-10 μg/mL

  • Validations

    Mouse IGFBP6 / IBP6 Immunohistochemistry(IHC) 15170

    Mouse IGFBP6 / IBP6 Immunohistochemistry(IHC) 15170

  • Background
    Insulin-like growth factor binding protein 6 (IGFBP6) is a 24-kDa protein that binds insulin-like growth factor 1 (IGF-1) and IGF-2 with high affinity and inhibits IGF action in vitro. The Insulin-like growth factor-binding protein also known as IGFBP serves as a carrier protein for Insulin-like growth factor 1. IGFBPs are clearly distinct but are sharing regions with strong homology. All members of the IGFBP family bind IGF-I and IGF-II with about equal affinity. Insulin-like growth factor (IGF) binding proteins (IGFBPs) have been shown to either inhibit or enhance the action of IGF, or act in an IGF-independent manner in the prostate. IGF-binding protein-4 (IGFBP-4) inhibits IGF-I action in vitro and is the most abundant IGFBP in the rodent arterial wall. IGFBP6 is directly downregulated by the beta-catenin/TCF complex in desmoid tumors, and imply a role for the IGF axis in the proliferation of desmoid tumors. There is mounting evidence that the structure of the IGFBP proteins plays a key role in the regulation of IGF bioavailability, by modulating its molecular size, capillary membrane permeability, target tissue specificity, cell membrane adherence and IGF affinity.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"